Neil Drake serves as Executive at OBALON THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Neil Drake has executed 10 insider transactions totaling $19.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 23, 2018 involved receiving (via award) 13,736 shares valued at $25.0K.
Neil Drake currently holds 61,267 shares of OBALON THERAPEUTICS INC (OBLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Neil Drake has been a net buyer of OBLN stock. They have purchased $19.8K and sold $0 worth of shares.
Neil Drake's most recent insider trade was on Aug 23, 2018, when they sold 13,736 shares at $1.82 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 30, 2018 | OBLN | $9.0K | Award | 2,743 | $3.27 | Discretionary |
| Mar 15, 2018 | OBLN | $19.8K | Purchase | 5,000 | $3.96 | Discretionary |
| Feb 2, 2018 | OBLN | $10.5K | Option Exercise | 5,746 | $1.83 | Discretionary |
| Feb 2, 2018 | OBLN | $2.8K | Option Exercise | 3,641 | $0.76 | Discretionary |
| Feb 2, 2018 | OBLN | $7.6K | Option Exercise | 4,310 | $1.77 | Discretionary |
| Feb 2, 2018 | OBLN | $300 | Option Exercise | 229 | $1.31 | Discretionary |
| Oct 31, 2017 | OBLN | $12.5K | Award | 1,743 | $7.17 | Discretionary |
| Apr 30, 2017 | OBLN | $15.0K | Award | 1,661 | $9.03 | Discretionary |